Current and future PrEP medications and modalities: on-demand, injectables, and topicals

MR Beymer, IW Holloway, C Pulsipher… - Current hiv/aids …, 2019 - Springer
Abstract Purpose of Review Pre-exposure prophylaxis (PrEP) is a potent HIV prevention
strategy, but uptake of daily oral PrEP remains low. This review covers PrEP agents currently …

Topical microbicides in HIV prevention: state of the promise

JM Baeten, CW Hendrix, SL Hillier - Annual review of medicine, 2020 - annualreviews.org
HIV topical microbicides are products with anti-HIV activity, generally incorporating a direct-
acting antiretroviral agent, that when applied to the vagina or rectum have the potential to …

Incentives conditioned on tenofovir levels to support PrEP adherence among young South African women: a randomized trial

CL Celum, K Gill, JF Morton, G Stein… - Journal of the …, 2020 - Wiley Online Library
Introduction HIV incidence remains high among African adolescent girls and young women
(AGYW), who would benefit from pre‐exposure prophylaxis (PrEP). Strategies to increase …

Pre-exposure prophylaxis for HIV prevention preferences among young adult African American men who have sex with men

RR Patel, JS Crane, J López, PA Chan, AY Liu… - PloS one, 2018 - journals.plos.org
Pre-exposure prophylaxis (PrEP) is effective in preventing HIV infections among men who
have sex with men (MSM). PrEP uptake and adherence remain low and product preferences …

A systematic review of sexuality measurement in transgender and gender diverse populations.

JA Puckett, K Glozier, D Kimball… - Psychology of Sexual …, 2021 - psycnet.apa.org
Research related to the lives of transgender and gender diverse (TGD) people has grown
substantially in recent years. One area of such growth has been research on TGD people's …

Preferences regarding emerging HIV prevention technologies among Toronto men who have sex with men: a discrete choice experiment

DHS Tan, J Rana, Z Tengra, TA Hart, J Wilton… - Scientific Reports, 2021 - nature.com
New forms of HIV pre-exposure prophylaxis (PrEP) include long-acting injectables and
topical microbicides, each with unique attributes that may appeal to distinct users. We used …

[HTML][HTML] Challenges and solutions implementing an SMS text message-based survey CASI and adherence reminders in an international biomedical HIV PrEP study …

W Brown III, R Giguere, A Sheinfil, M Ibitoye… - Journal of biomedical …, 2018 - Elsevier
Background We implemented a text message-based Short Message Service computer-
assisted self-interviewing (SMS-CASI) system to aid adherence and monitor behavior in …

HIV antiretroviral pre‐exposure prophylaxis: development challenges and pipeline promise

CW Hendrix - Clinical Pharmacology & Therapeutics, 2018 - Wiley Online Library
The US Food and Drug Administration (FDA) approved oral daily tenofovir/emtricitabine
(Truvada) for pre‐exposure prophylaxis of human immunodeficiency virus (HIV) infection in …

Current state of microbicide development

YL Traore, Y Chen, EA Ho - Clinical Pharmacology & …, 2018 - Wiley Online Library
Efforts in develo** an effective vaccine for human immunodeficiency virus (HIV) has been
challenging as HIV strains are highly variable and exhibit extraordinary mutability. Despite …

Treatment with commonly used antiretroviral drugs induces a type I/III interferon signature in the gut in the absence of HIV infection

SM Hughes, CN Levy, FL Calienes, JD Stekler… - Cell Reports …, 2020 - cell.com
Tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) are used for HIV treatment and
prevention. Previously, we found that topical rectal tenofovir gel caused immunological …